Myasthenia gravis associated with nivolumab therapy in patient with lung adenocarcinoma
Conclusions
It is important for neurologists and oncologists to consider nivolumab as a possible aetiology of MG and to discontinue it before considering aggressive treatment for MG.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Prabhaharan, S., Joshi, A., Urkude, R. Tags: Abstracts Source Type: research
More News: Adenocarcinoma | Alimta | Autoimmune Disease | Brain | Brain Cancers | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Lung Cancer | Melanoma | Myasthenia Gravis | Neurology | Neurosurgery | Non-Small Cell Lung Cancer | Pain | PET Scan | Prednisolone | Psychiatry | Skin Cancer | Study | Thoracotomy